Macitentan Phase III PAH outcome study results to be presented at CHEST 2012
03:01 EDT 10 Sep 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Actelion Pharmaceuticals Ltd /
Macitentan Phase III PAH outcome study results to be presented at CHEST 2012
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. ALLSCHWIL/BASEL, SWITZERL...
Other Sources for this Article
More From BioPortfolio on "Macitentan Phase III PAH outcome study results to be presented at CHEST 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
